Alessandra Cesano - 08 Feb 2024 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 18:15:07 UTC
Previous filing
04 Jan 2024
Next filing
28 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +74,000 $0.000000 74,000 08 Feb 2024 Common Stock 74,000 $11.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in 36 equal monthly installments starting one month after grant date of February 8, 2024.